Compare Cipher Mining Inc (CIFR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipher Mining Inc vs BIO-TECHNE Corp — how do they compare? Cipher Mining Inc trades at $17.8 (market cap $6.78B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Cipher Mining Inc pays none. Which is the better fit depends on your goals.
| CIFR | TECH | |
|---|---|---|
Market Cap | $6.78B | $11.24B |
Sector | Basic Materials | Health |
52-Week High | $29.18 | $72.29 |
52-Week Low | $4.72 | $43.31 |
Enterprise Value | $11.53B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cipher Digital (CIFR) trades at $17.18, down 5.66% amid bearish technical signals and recent earnings misses. The company is transitioning from Bitcoin mining to AI data center operations, with significant negative profitability metrics including -585.75% net income margin and -170.77% ROE. Recent news highlights accelerated HPC delivery and project financing progress while the stock faces valuation concerns with P/S of 34.3 and EV/EBITDA of 54.24.
Despite unanimous analyst buy ratings and a $31.78 consensus target, CIFR faces substantial execution risks in its business pivot. The transition requires massive capital investment with negative cash flows, while current valuation appears stretched relative to financial performance. The stock's near-term trajectory depends on successful AI revenue ramp-up and project execution.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cipher Mining Inc
Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.
Read more on CIFR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
